Product Information
PHENTERMINE 15 MG CAPSULE is a generic product labeled by Aurolife Pharma LLC, priced at $0.0888 per EA under NDC 13107010501. Its NADAC has been published 419 times since Aug 16, 2017.
Strength
15 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107010501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204318On Market Since
3/20/2017
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 15 MG CAPSULE has been published 419 times since Aug 16, 2017, and over the history we have for it it has declined 57.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0888 per EA |
|---|---|
| All-time high | $0.2927 (Jan 10, 2018) |
| All-time low | $0.0784 (Nov 20, 2024) |
| 52-week high | $0.1014 |
| 52-week low | $0.0888 |
| Median price | $0.1352 |
| Average price | $0.1449 |
| Largest weekly change | +44.3% (Aug 21, 2024) |
| Weeks tracked | 419 |
| Tracking since | Aug 16, 2017 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 15 MG CAPSULE, manufactured by Aurolife Pharma LLC, is $0.0888 per EA (NDC 13107010501), effective Aug 20, 2025.
How has the price of PHENTERMINE 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 15 MG CAPSULE has declined 57.1%. It has been tracked across 419 weekly CMS publications since Aug 16, 2017.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 15 MG CAPSULE?
Since Aug 16, 2017, the NADAC for PHENTERMINE 15 MG CAPSULE has ranged from a low of $0.0784 (Nov 20, 2024) to a high of $0.2927 (Jan 10, 2018), with a median of $0.1352 per EA.
Are there cheaper alternatives to PHENTERMINE 15 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE 15 MG CAPSULE, is $0.0828 per EA — about 7% below PHENTERMINE 15 MG CAPSULE.
Who manufactures PHENTERMINE 15 MG CAPSULE?
PHENTERMINE 15 MG CAPSULE (NDC 13107010501) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification